Cost and Budget Impact Analysis of an Accurate Intraoperative Sentinel Lymph Node Diagnosis for Breast Cancer Metastasis | Zendy

Yuko Saruta | Zendy; Jaume PuigJunoy | Zendy

Open Access

Cost and Budget Impact Analysis of an Accurate Intraoperative Sentinel Lymph Node Diagnosis for Breast Cancer Metastasis

Author(s) -

Yuko Saruta,

Jaume PuigJunoy

Publication year - 2016

Publication title -

applied health economics and health policy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.099

H-Index - 40

eISSN - 1179-1896

pISSN - 1175-5652

DOI - 10.1007/s40258-016-0235-4

Subject(s) - medicine , breast cancer , sentinel lymph node , health care , health economics , economic evaluation , sentinel node , surgery , general surgery , emergency medicine , radiology , cancer , public health , pathology , economics , economic growth

Conventional intraoperative sentinel lymph node biopsy (SLNB) in breast cancer (BC) has limitations in establishing a definitive diagnosis of metastasis intraoperatively, leading to an unnecessary second operation. The one-step nucleic amplification assay (OSNA) provides accurate intraoperative diagnosis and avoids further testing. Only five articles have researched the cost and cost effectiveness of this diagnostic tool, although many hospitals have adopted it, and economic evaluation is needed for budget holders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research